Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) EBT Margin: 2010-2018

Historic EBT Margin for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -2,956.58%.

  • EyePoint Pharmaceuticals' EBT Margin fell 139658.00% to -2,956.58% in Q3 2018 from the same period last year, while for Sep 2018 it was -1,553.93%, marking a year-over-year decrease of 132731.00%. This contributed to the annual value of -1,795.71% for FY2018, which is 155052.00% down from last year.
  • As of Q3 2018, EyePoint Pharmaceuticals' EBT Margin stood at -2,956.58%, which was down 116.11% from -1,368.11% recorded in Q2 2018.
  • EyePoint Pharmaceuticals' EBT Margin's 5-year high stood at 82.16% during Q3 2014, with a 5-year trough of -5,808.00% in Q4 2017.
  • Moreover, its 3-year median value for EBT Margin was -1,560.00% (2017), whereas its average is -1,837.00%.
  • Over the last 5 years, EyePoint Pharmaceuticals' EBT Margin had its largest YoY gain of 124,102bps in 2017, and its largest YoY loss of 580,688bps in 2017.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' EBT Margin stood at -789.44% in 2014, then crashed by 20,447bps to -993.92% in 2015, then surged by 99,279bps to -1.12% in 2016, then crashed by 580,688bps to -5,808.00% in 2017, then tumbled by 139,658bps to -2,956.58% in 2018.
  • Its last three reported values are -2,956.58% in Q3 2018, -1,368.11% for Q2 2018, and -504.09% during Q1 2018.